Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

NCT02032784 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

33

Enrollment

OTHER

Sponsor class

Stopped Difficult to enroll subjects

Conditions

Adenoma

Interventions

DRUG: octreotide
OTHER: No Octreotide

Sponsor

AdventHealth